Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing

Haematologica

Volumn 92, Issue 12, 2007, Pages 1671-1678

  De Vries, Jeltje F ^a   Von Dem Borne, Peter A ^a   Van Luxemburg Heijs, Simone A P ^a   Heemskerk, Mirjam H M ^a   Willemze, Roel ^a   Falkenburg, J H Frederik ^a   Barge, Renèe M Y ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Cytotoxic T lymphocyte; Fas; Flip death receptor pathway; Retroviral vector

Indexed keywords

DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; GRANZYME B; PERFORIN; RETROVIRUS VECTOR;

ARTICLE; CELL CLONING; CELL KILLING; CHRONIC MYELOID LEUKEMIA; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; PROTEIN SECRETION; TARGET CELL; TUMOR CELL;

APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CELL DEATH; GRANZYMES; HUMANS; IMMUNITY, CELLULAR; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PERFORIN; RECEPTORS, TUMOR NECROSIS FACTOR; RETROVIRIDAE; T-LYMPHOCYTES; TIME FACTORS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 37049015795     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11308     Document Type: Article

References (38)

1. Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994;1:343-46.
2. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic padiways. Nature 1994; 370:650-2.
3. Bleackley RC, Lobe CG, Duggan B, Ehrman N, Fregeau C, Meier M. The isolation and characterization of a family of serine protease genes Expressed in activated cytotoxic lymphocytes-T. Immunol Rev 1988; 103:5-19.
4. Tschopp J, Nabholz M. Perforin-mediated target-ccell lysis by cytolytic Iymphocyte-T. Ann Rev Immunol 1990;8:279-302.
5. Yang XH, Stennicke HR, Wang BK, Green DR, Janicke RU, Srinivasan A, et al. Granzyme B mimics apical caspases - description of a unified pathway for trans-activation of executioner caspase-3 and -7. J Biol Chem 1998;273:34278-83.
6. MacDonald G, Shi LF, Velde CV, Lieberman J, Greenberg AH. Mitochondria-dependent and -independent regulation of granzyme B-induced apoptosis. J Exp Med 1999; 189:131-43.
7. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, et al. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994; 91:4930-4.
8. Chen GQ, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002;296:1634-5.
9. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 2001;20:1063-75.
10. Nagata S. Fas ligand-induced apoptosis. Ann Rev Genet 1999; 33:29-55.
11. Berke G. The Ctls kiss of death. Cell 1995;81:9-12.
12. Kagi D, Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol 1996;8:472-7.
13. vandenBroek MF, Kagi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, et al. Decreased tumor surveillance in perforin-deficient mice. J Exp Med 1996; 184:1781-90.
14. Waterhouse NJ, Sutton VR, Sedelies KA, Ciccone A, Jenkins M, Turner SJ, et al. Cytotoxic T lymphocyte-induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis. J Cell Biol 2006;173:133-44.
15. Ju ST, Panka DJ, Cui HL, Ettinger R, Elkhatib M, Sherr DH, et al. Fas(Cd95) Fasl interactions required for programmed cell-death after T-cell activation. Nature 1995; 373:444-8.
16. Lynch DH, Ramsdell F, Alderson MR. Fas and Fasl in the homeostatic regulation of immune-responses. Immunol Today 1995;16:569-74.
17. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
18. Russell JH. Activation-Induced Death of mature T-cells in the regulation of immune-responses. Curr Opin Immunol 1995;7:382-8.
19. Rieuxlaucat F, Ledeist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-9.
20. Watanabefukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-7.
21. Smyth MJ, Sedgwick JD. Delayed kinetics of tumor necrosis factor-mediated bystander lysis by peptide-specific CD8(+) cytotoxic T lymphocytes. Eur J Immunol 1998; 28:4162-9.
22. Topham DJ, Tripp RA, Doherty PC. CD8(+) T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997;159: 5197-200.
23. Zajac AJ, Quinn DG, Cohen PL, Frelinger JA. Fas-dependent CD4(+) cytotoxic T-cell-mediated pathogenesis during virus infection. Proc Natl Acad Sci USA 1996;93:14730-5.
24. Maecker HT, Hedjbeli S, Alzona M, Le PT. Comparison of apoptosis signaling through T cell receptor, Fas, and calcium ionophore. Exp Cell Res 1996;222:95-102.
25. Jedema I, Barge RM, Willemze R, Falkenburg JH. High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment. Leukemia 2003;17:576-84.
26. Shresta S, Macivor DM, Heusel JW, Russell JH, Ley TJ. Natural-killer and lymphokine-activated killer-cells require granzyme-B for the rapid induction of apoptosis in susceptible target-cells. Proc Natl Acad Sci USA 1995;92:5679-83.
27. Irmler M, Thome M, Hahne M, Schneider P, Hofmann B, Steiner V, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388:190-5.
28. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386:517-21.
29. Vogt MHJ, de Paus RA, Voogt PJ, Willemze R, Falkenburg JHF. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 2000;95:1100-5.
30. Von dem Borne PA, Luxemburg-Heijs SAP, Heemskerk MHM, Jedema I, Mulder A, Willemze R, et al. Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells. Leukemia 2006;20:1040-6.
31. Jedema I, van der Werff NM, Barge RM, Willemze R, Falkenburg JH. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004; 103: 2677-82.
32. Kinsella TM, Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Human Gene Therapy 1996;7:1405-13.
33. Heemskerk MHM, de Paus RA, Lurvink EGA, Koning F, Mulder A, Willemze R, et al. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Nad Acad Sci USA 2001; 98:6806-11.
34. Veuger MJT, Honders MW, Willemze R, Barge RMY. Deoxycytidine kinase expression and activity in patients widi resistant versus sensitive acute myeloid leukemia. Eur J Haematol 2002;69:171-8.
35. Yasukawa M, Ohminami H, Arai J, Kasahara Y, Ishida Y, Fujita S. Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Blood 2000; 95:2352-5.
36. Liu CC, Persechini PM, Young JDE. Perforin and lymphocyte-mediated cytolysis. Immunol Rev 1995; 146: 145-75.
37. Rochel N, Cowan JA. Negative cooperativity exhibited by the lytic amino-terminal domain of human perforin: implications for perforin-mediated cell lysis. Chem Biol 1996; 3:31-6.
38. Simon MM, Hausmann M, Tran T, Ebnet K, Tschopp J, ThaHla R, Mullbacher A. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med 1997;186:1781-6.